{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,6]],"date-time":"2026-10-06T01:51:49Z","timestamp":1791251509880,"version":"4.1.0"},"reference-count":127,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,7,11]],"date-time":"2026-07-11T00:00:00Z","timestamp":1783728000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2026,10,6]],"date-time":"2026-10-06T00:00:00Z","timestamp":1791244800000},"content-version":"vor","delay-in-days":87,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Cell Death Discov."],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>High Mobility Group A (HMGA) proteins function as non-histone chromatin-associated architectural regulators that modulate gene transcription by modifying chromatin structure rather than binding DNA in a sequence-specific manner. By altering chromatin conformation, HMGA proteins coordinate complex transcriptional programs essential in both physiological and pathological conditions. This review highlights their emerging roles in the context of the nervous system, brain tumorigenesis, and neurodegeneration. We discuss how HMGA-mediated chromatin remodeling and transcriptional regulation influence neurodevelopmental processes, regulating neural stem cell proliferation, differentiation, and lineage specification. We also highlight evidence linking HMGA dysregulation to malignant transformation and progression of brain tumors, where these proteins support oncogenic transcriptional networks. Finally, we explore their possible involvement in molecular pathways associated with neurodegenerative disorders. By integrating findings from developmental neurobiology, oncology, and neurodegeneration research, we aim to provide a comprehensive overview of HMGA proteins as pivotal regulators of neural homeostasis and highlights their potential as biomarkers and therapeutic targets in neurological diseases.<\/jats:p>","DOI":"10.1038\/s41420-026-03242-4","type":"journal-article","created":{"date-parts":[[2026,7,10]],"date-time":"2026-07-10T22:52:48Z","timestamp":1783723968000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["HMGA proteins in the nervous system: role in brain tumorigenesis and neurodegeneration"],"prefix":"10.1038","volume":"12","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-4545-0737","authenticated-orcid":false,"given":"Carolina","family":"Can\u00e8","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5332-6774","authenticated-orcid":false,"given":"Simona","family":"Paladino","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2719-0994","authenticated-orcid":false,"given":"Andrea","family":"Conte","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4078-8528","authenticated-orcid":false,"given":"Giovanna Maria","family":"Pierantoni","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,7,11]]},"reference":[{"key":"3242_CR1","first-page":"289","volume":"32","author":"I Cleynen","year":"2008","unstructured":"Cleynen I, Van de Ven WJ. The HMGA proteins: a myriad of functions. Int J Oncol. 2008;32:289\u2013305.","journal-title":"Int J Oncol"},{"key":"3242_CR2","doi-asserted-by":"publisher","first-page":"213","DOI":"10.1007\/s13237-018-0257-4","volume":"61","author":"R Mallik","year":"2018","unstructured":"Mallik R, Kundu A, Chaudhuri S. High mobility group proteins: the multifaceted regulators of chromatin dynamics. Nucleus. 2018;61:213\u201326.","journal-title":"Nucleus"},{"key":"3242_CR3","doi-asserted-by":"publisher","first-page":"5","DOI":"10.3389\/fcell.2014.00005","volume":"2","author":"N Ozturk","year":"2014","unstructured":"Ozturk N, Singh I, Mehta A, Braun T, Barreto G. HMGA proteins as modulators of chromatin structure during transcriptional activation. Front Cell Dev Biol. 2014;2:5.","journal-title":"Front Cell Dev Biol"},{"key":"3242_CR4","doi-asserted-by":"publisher","first-page":"3710","DOI":"10.3390\/ijms21103710","volume":"21","author":"L Su","year":"2020","unstructured":"Su L, Deng Z, Leng F. The mammalian high mobility group protein AT-Hook 2 (HMGA2): biochemical and biophysical properties, and its association with adipogenesis. Int J Mol Sci. 2020;21:3710.","journal-title":"Int J Mol Sci"},{"key":"3242_CR5","doi-asserted-by":"publisher","first-page":"8863","DOI":"10.3390\/ijms25168863","volume":"25","author":"S Battista","year":"2024","unstructured":"Battista S, Fedele M, Secco L, Ingo AMD, Sgarra R, Manfioletti G. Binding to the other side: the AT-Hook DNA-binding domain allows nuclear factors to exploit the DNA minor groove. Int J Mol Sci. 2024;25:8863.","journal-title":"Int J Mol Sci"},{"key":"3242_CR6","doi-asserted-by":"publisher","first-page":"2431","DOI":"10.1093\/nar\/gkac115","volume":"50","author":"A Garabedian","year":"2022","unstructured":"Garabedian A, Jeanne Dit Fouque K, Chapagain PP, Leng F, Fernandez-Lima F. AT-hook peptides bind the major and minor groove of AT-rich DNA duplexes. Nucleic Acids Res. 2022;50:2431\u20139.","journal-title":"Nucleic Acids Res"},{"key":"3242_CR7","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-024-77522-3","volume":"14","author":"JJ Nu\u00e9-Martinez","year":"2024","unstructured":"Nu\u00e9-Martinez JJ, Maturana M, Lagartera L, Rodr\u00edguez-Guti\u00e9rrez JA, Boer R, Campos JL, et al. Crystal structure of the HMGA AT-hook 1 domain bound to the minor groove of AT-rich DNA and inhibition by antikinetoplastid drugs. Sci Rep. 2024;14:26173.","journal-title":"Sci Rep"},{"key":"3242_CR8","doi-asserted-by":"publisher","first-page":"205","DOI":"10.1016\/S0959-437X(00)00180-5","volume":"11","author":"M Merika","year":"2001","unstructured":"Merika M, Thanos D. Enhanceosomes. Curr Opin Genet Dev. 2001;11:205\u20138.","journal-title":"Curr Opin Genet Dev"},{"key":"3242_CR9","doi-asserted-by":"publisher","first-page":"18338","DOI":"10.1016\/S0021-9258(19)81364-9","volume":"263","author":"KR Johnson","year":"1988","unstructured":"Johnson KR, Lehn DA, Elton TS, Barr PJ, Reeves R. Complete murine cDNA sequence, genomic structure and tissue expression of the high mobility group protein HMG-I (Y). J Biol Chem. 1988;263:18338\u201342.","journal-title":"J Biol Chem"},{"key":"3242_CR10","doi-asserted-by":"publisher","first-page":"1583","DOI":"10.1093\/carcin\/22.10.1583","volume":"22","author":"M Fedele","year":"2001","unstructured":"Fedele M, Battista S, Manfioletti G, Croce CM, Giancotti V, Fusco A. Role of the high mobility group A proteins in human lipomas. Carcinog. 2001;22:1583\u201391.","journal-title":"Carcinog"},{"key":"3242_CR11","doi-asserted-by":"publisher","first-page":"8961","DOI":"10.1074\/jbc.M407348200","volume":"280","author":"DD Edberg","year":"2005","unstructured":"Edberg DD, Adkins JN, Springer DL, Reeves R. Dynamic and differential in vivo modifications of the isoform HMGA1a and HMGA1b chromatin proteins. J Biol Chem. 2005;280:8961\u201373.","journal-title":"J Biol Chem"},{"key":"3242_CR12","doi-asserted-by":"publisher","first-page":"3644","DOI":"10.1038\/sj.onc.1205501","volume":"21","author":"P Chieffi","year":"2001","unstructured":"Chieffi P, Battista S, Barchi M, Di Agostino S, Pierantoni GM, Fedele M, et al. HMGA1 and HMGA2 protein expression in mouse spermatogenesis. Oncogene. 2001;21:3644\u201350.","journal-title":"Oncogene"},{"key":"3242_CR13","doi-asserted-by":"publisher","first-page":"24","DOI":"10.1016\/j.bbaexp.2005.03.006","volume":"1729","author":"S Hauke","year":"2005","unstructured":"Hauke S, Leopold S, Schlueter C, Flohr AM, Escobar HM, Rogalla P, et al. Extensive expression studies revealed a complex alternative splicing pattern of the HMGA2 gene. BBA Gene Struct Expr. 2005;1729:24\u201331.","journal-title":"BBA Gene Struct Expr"},{"key":"3242_CR14","doi-asserted-by":"publisher","first-page":"664","DOI":"10.3892\/br.2014.303","volume":"2","author":"J Zheng","year":"2014","unstructured":"Zheng J, Yu S, Jiang Z, Shi C, Li J, Du X, et al. Microarray comparison of the gene expression profiles in the adult vs. embryonic day 14 rat liver. Biomed Rep. 2014;2:664\u201370.","journal-title":"Biomed Rep"},{"key":"3242_CR15","doi-asserted-by":"publisher","DOI":"10.1155\/2018\/3698078","volume":"2018","author":"V Giancotti","year":"2018","unstructured":"Giancotti V, Bergamin N, Cataldi P, Rizzi C. Epigenetic contribution of high-mobility group A proteins to stem cell properties. Int J Cell Biol. 2018;2018:3698078.","journal-title":"Int J Cell Biol"},{"key":"3242_CR16","doi-asserted-by":"publisher","first-page":"1025","DOI":"10.1101\/gad.1540407","volume":"21","author":"YS Lee","year":"2007","unstructured":"Lee YS, Dutta A. The tumor suppressor microRNA let-7 represses the HMGA2 oncogene. Genes Dev. 2007;21:1025\u201330.","journal-title":"Genes Dev"},{"key":"3242_CR17","first-page":"41","volume":"618","author":"C Hogan","year":"2007","unstructured":"Hogan C, Varga-Weisz P. The regulation of ATP-dependent nucleosome remodeling factors. Mutat Res\/Fundam Mol Mech Mutagen. 2007;618:41\u201351.","journal-title":"Mutat Res\/Fundam Mol Mech Mutagen"},{"key":"3242_CR18","first-page":"2174","volume":"11","author":"M De Martino","year":"2021","unstructured":"De Martino M, Nicolau-Neto P, Pinto LFR, Traverse-Glehen A, Bachy E, Gigantino V, et al. HMGA1 induces EZH2 overexpression in human B-cell lymphomas. Am J Cancer Res. 2021;11:2174.","journal-title":"Am J Cancer Res"},{"key":"3242_CR19","doi-asserted-by":"publisher","first-page":"700","DOI":"10.4252\/wjsc.v7.i4.700","volume":"7","author":"R Montalb\u00e1n-Loro","year":"2015","unstructured":"Montalb\u00e1n-Loro R, Domingo-Muelas A, Bizy A, Ferr\u00f3n SR. Epigenetic regulation of stemness maintenance in the neurogenic niches. World J Stem Cells. 2015;7:700.","journal-title":"World J Stem Cells"},{"key":"3242_CR20","doi-asserted-by":"publisher","first-page":"23","DOI":"10.3389\/fncel.2017.00023","volume":"11","author":"M Podobinska","year":"2017","unstructured":"Podobinska M, Szablowska-Gadomska I, Augustyniak J, Sandvig I, Sandvig A, Buzanska L. Epigenetic modulation of stem cells in neurodevelopment: the role of methylation and acetylation. Front Cell Neurosci. 2017;11:23.","journal-title":"Front Cell Neurosci"},{"key":"3242_CR21","doi-asserted-by":"publisher","first-page":"654","DOI":"10.3390\/ijms21020654","volume":"21","author":"R Vignali","year":"2020","unstructured":"Vignali R, Marracci S. HMGA genes and proteins in development and evolution. Int J Mol Sci. 2020;21:654.","journal-title":"Int J Mol Sci"},{"key":"3242_CR22","doi-asserted-by":"publisher","first-page":"362","DOI":"10.3390\/ijms21010362","volume":"21","author":"S Parisi","year":"2020","unstructured":"Parisi S, Piscitelli S, Passaro F, Russo T. HMGA proteins in stemness and differentiation of embryonic and adult stem cells. Int J Mol Sci. 2020;21:362.","journal-title":"Int J Mol Sci"},{"key":"3242_CR23","doi-asserted-by":"publisher","first-page":"227","DOI":"10.1016\/j.cell.2008.09.017","volume":"135","author":"J Nishino","year":"2008","unstructured":"Nishino J, Kim I, Chada K, Morrison SJ. Hmga2 promotes neural stem cell self-renewal in young but not old mice by reducing p16Ink4a and p19Arf Expression. Cell. 2008;135:227\u201339.","journal-title":"Cell"},{"key":"3242_CR24","doi-asserted-by":"publisher","first-page":"1127","DOI":"10.1038\/nn.3165","volume":"15","author":"Y Kishi","year":"2012","unstructured":"Kishi Y, Fujii Y, Hirabayashi Y, Gotoh Y. HMGA regulates the global chromatin state and neurogenic potential in neocortical precursor cells. Nat Neurosci. 2012;15:1127\u201333.","journal-title":"Nat Neurosci"},{"key":"3242_CR25","doi-asserted-by":"publisher","first-page":"1554","DOI":"10.1002\/glia.23818","volume":"68","author":"T Nakagawa","year":"2020","unstructured":"Nakagawa T, Wada Y, Katada S, Kishi Y. Epigenetic regulation for acquiring glial identity by neural stem cells during cortical development. Glia. 2020;68:1554\u201367.","journal-title":"Glia"},{"key":"3242_CR26","doi-asserted-by":"publisher","DOI":"10.1186\/s12915-016-0246-5","volume":"14","author":"A Navarra","year":"2016","unstructured":"Navarra A, Musto A, Gargiulo A, Petrosino G, Pierantoni GM, Fusco A, et al. Hmga2 is necessary for Otx2-dependent exit of embryonic stem cells from the pluripotent ground state. BMC Biol. 2016;14:24.","journal-title":"BMC Biol"},{"key":"3242_CR27","doi-asserted-by":"publisher","first-page":"1289","DOI":"10.1038\/s41401-019-0338-1","volume":"41","author":"R Li","year":"2020","unstructured":"Li R, Li DH, Zhang HY, Wang J, Li XK, Xiao J. Growth factors-based therapeutic strategies and their underlying signaling mechanisms for peripheral nerve regeneration. Acta Pharm Sin. 2020;41:1289\u20131300.","journal-title":"Acta Pharm Sin"},{"key":"3242_CR28","doi-asserted-by":"publisher","first-page":"1675","DOI":"10.2353\/ajpath.2009.090069","volume":"175","author":"SI Akaboshi","year":"2009","unstructured":"Akaboshi SI, Watanabe S, Hino Y, Sekita Y, Xi Y, Araki K, et al. HMGA1 is induced by Wnt\/\u03b2-catenin pathway and maintains cell proliferation in gastric cancer. Am J Pathol. 2009;175:1675\u201385.","journal-title":"Am J Pathol"},{"key":"3242_CR29","doi-asserted-by":"publisher","first-page":"693","DOI":"10.3892\/ijmm.2015.2062","volume":"35","author":"X Zu","year":"2015","unstructured":"Zu X, Zhong J, Tan J, Tan L, Yang D, Zhang Q, et al. TGF-\u03b21 induces HMGA1 expression in human breast cancer cells: implications of the involvement of HMGA1 in TGF-\u03b2 signaling. Int J Mol Med. 2015;35:693\u2013701.","journal-title":"Int J Mol Med"},{"key":"3242_CR30","doi-asserted-by":"publisher","DOI":"10.1016\/j.cellsig.2019.109386","volume":"63","author":"Y Cheng","year":"2019","unstructured":"Cheng Y, Cheng T, Zhao Y, Qu Y. HMGA1 exacerbates tumor progression by activating miR-222 through PI3K\/Akt\/MMP-9 signaling pathway in uveal melanoma. Cell Signal. 2019;63:109386.","journal-title":"Cell Signal"},{"key":"3242_CR31","doi-asserted-by":"publisher","first-page":"12","DOI":"10.1016\/j.neures.2018.09.005","volume":"138","author":"R Kageyama","year":"2019","unstructured":"Kageyama R, Shimojo H, Ohtsuka T. Dynamic control of neural stem cells by bHLH factors. Neurosci Res. 2019;138:12\u201318.","journal-title":"Neurosci Res"},{"key":"3242_CR32","doi-asserted-by":"publisher","first-page":"526","DOI":"10.1002\/mc.21887","volume":"52","author":"I Massimi","year":"2013","unstructured":"Massimi I, Guerrieri F, Petroni M, Veschi V, Truffa S, Screpanti I, et al. The HMGA1 protoncogene frequently deregulated in cancer is a transcriptional target of E2F1. Mol Carcinog. 2013;52:526\u201334.","journal-title":"Mol Carcinog"},{"key":"3242_CR33","doi-asserted-by":"publisher","first-page":"849","DOI":"10.3892\/ol.2021.13110","volume":"22","author":"D Li","year":"2021","unstructured":"Li D, Cao Y, Wang J, Yang H, Liu W, Cui J, et al. Regulatory effect between HMGA2 and the Wnt\/\u03b2-catenin signaling pathway in the carcinogenesis of sporadic colorectal tubular adenoma. Oncol Lett. 2021;22:849.","journal-title":"Oncol Lett"},{"key":"3242_CR34","doi-asserted-by":"publisher","first-page":"382","DOI":"10.1016\/j.tips.2012.04.003","volume":"33","author":"H Butz","year":"2012","unstructured":"Butz H, R\u00e1cz K, Hunyady L, Pat\u00f3cs A. Crosstalk between TGF-\u03b2 signaling and the microRNA machinery. Trends Pharm Sci. 2012;33:382\u201393.","journal-title":"Trends Pharm Sci"},{"key":"3242_CR35","doi-asserted-by":"publisher","first-page":"1297","DOI":"10.1158\/1078-0432.CCR-10-0993","volume":"17","author":"JJ Wei","year":"2011","unstructured":"Wei JJ, Wu X, Peng Y, Shi G, Olca B, Yang X, et al. Regulation of HMGA1 expression by microRNA-296 affects prostate cancer growth and invasion. Clin Cancer Res. 2011;17:1297\u2013305.","journal-title":"Clin Cancer Res"},{"key":"3242_CR36","doi-asserted-by":"publisher","first-page":"8341","DOI":"10.18632\/oncotarget.2202","volume":"5","author":"F Esposito","year":"2014","unstructured":"Esposito F, De Martino M, Petti MG, Forzati F, Tornincasa M, Federico A, et al. HMGA1 pseudogenes as candidate proto-oncogenic competitive endogenous RNAs. Oncotarget. 2014;5:8341.","journal-title":"Oncotarget"},{"key":"3242_CR37","doi-asserted-by":"publisher","first-page":"511","DOI":"10.1042\/BC20080213","volume":"101","author":"T Kaddar","year":"2009","unstructured":"Kaddar T, Rouault JP, Chien WW, Chebel A, Gadoux M, Salles G, et al. Two new miR-16 targets: caprin-1 and HMGA1, proteins implicated in cell proliferation. Biol Cell. 2009;101:511\u201324.","journal-title":"Biol Cell"},{"key":"3242_CR38","doi-asserted-by":"publisher","first-page":"534","DOI":"10.3892\/mmr.2016.6053","volume":"15","author":"N Sekimoto","year":"2017","unstructured":"Sekimoto N, Suzuki A, Suzuki Y, Sugano S. Expression of miR-26a exhibits a negative correlation with HMGA1 and regulates cancer progression by targeting HMGA1 in lung adenocarcinoma cells. Mol Med Rep. 2017;15:534\u201342.","journal-title":"Mol Med Rep"},{"key":"3242_CR39","doi-asserted-by":"publisher","first-page":"741","DOI":"10.1038\/bjc.2016.234","volume":"115","author":"KS Chandrasekaran","year":"2016","unstructured":"Chandrasekaran KS, Sathyanarayanan A, Karunagaran D. MicroRNA-214 suppresses growth, migration and invasion through a novel target, high mobility group AT-hook 1, in human cervical and colorectal cancer cells. Br J Cancer. 2016;115:741\u201351.","journal-title":"Br J Cancer"},{"key":"3242_CR40","doi-asserted-by":"publisher","first-page":"E1128","DOI":"10.1210\/jc.2011-3482","volume":"97","author":"D D\u2019Angelo","year":"2012","unstructured":"D\u2019Angelo D, Palmieri D, Mussnich P, Roche M, Wierinckx A, Raverot G, et al. Altered microRNA expression profile in human pituitary GH adenomas: down-regulation of miRNA targeting HMGA1, HMGA2, and E2F1. J Clin Endocrinol Metab. 2012;97:E1128\u201338.","journal-title":"J Clin Endocrinol Metab"},{"key":"3242_CR41","doi-asserted-by":"publisher","first-page":"2567","DOI":"10.2174\/1570159X21666230404103914","volume":"21","author":"F De Vito","year":"2023","unstructured":"De Vito F, Balletta S, Caioli S, Musella A, Guadalupi L, Vanni V, et al. MiR-142-3p is a critical modulator of TNF-mediated neuronal toxicity in multiple sclerosis. Curr Neuropharmacol. 2023;21:2567\u201382.","journal-title":"Curr Neuropharmacol"},{"key":"3242_CR42","doi-asserted-by":"publisher","first-page":"426","DOI":"10.3390\/ph17040426","volume":"17","author":"A Lui","year":"2024","unstructured":"Lui A, Do T, Alzayat O, Yu N, Phyu S, Santuya HJ, et al. Tumor suppressor MicroRNAs in clinical and preclinical trials for neurological disorders. Pharmaceuticals. 2024;17:426.","journal-title":"Pharmaceuticals"},{"key":"3242_CR43","doi-asserted-by":"publisher","first-page":"241","DOI":"10.2174\/1567202617666200414142637","volume":"17","author":"Y Liu","year":"2020","unstructured":"Liu Y, Wang L, Xie F, Wang X, Hou Y, Wang X, et al. Overexpression of miR-26a-5p suppresses tau phosphorylation and A\u03b2 accumulation in the Alzheimer\u2019s disease mice by targeting DYRK1A. Curr Neurovasc Res. 2020;17:241\u20138.","journal-title":"Curr Neurovasc Res"},{"key":"3242_CR44","doi-asserted-by":"publisher","first-page":"91","DOI":"10.3389\/fncel.2018.00091","volume":"12","author":"H Yang","year":"2018","unstructured":"Yang H, Wang H, Shu Y, Li X. miR-103 promotes neurite outgrowth and suppresses cells apoptosis by targeting prostaglandin-endoperoxide synthase 2 in cellular models of Alzheimer\u2019s disease. Front Cell Neurosci. 2018;12:91.","journal-title":"Front Cell Neurosci"},{"key":"3242_CR45","doi-asserted-by":"publisher","first-page":"1576","DOI":"10.1126\/science.1137999","volume":"315","author":"C Mayr","year":"2007","unstructured":"Mayr C, Hemann MT, Bartel DP. Disrupting the pairing between let-7 and Hmga2 enhances oncogenic transformation. Science. 2007;315:1576\u20139.","journal-title":"Science"},{"key":"3242_CR46","doi-asserted-by":"publisher","first-page":"717","DOI":"10.3390\/ijms21030717","volume":"21","author":"R Sgarra","year":"2020","unstructured":"Sgarra R, Pegoraro S, D\u2019Angelo D, Ros G, Zanin R, Sgubin M, et al. High Mobility Group A (HMGA): chromatin nodes controlled by a knotty miRNA network. Int J Mol Sci. 2020;21:717.","journal-title":"Int J Mol Sci"},{"key":"3242_CR47","doi-asserted-by":"publisher","first-page":"e0200602","DOI":"10.1371\/journal.pone.0200602","volume":"13","author":"K Derkow","year":"2018","unstructured":"Derkow K, R\u00f6ssling R, Schipke C, Kr\u00fcger C, Bauer J, F\u00e4hling M, et al. Distinct expression of the neurotoxic microRNA family let-7 in the cerebrospinal fluid of patients with Alzheimer\u2019s disease. PLoS ONE. 2018;13:e0200602.","journal-title":"PLoS ONE"},{"key":"3242_CR48","first-page":"20","volume":"5","author":"J Godlewski","year":"2019","unstructured":"Godlewski J, Lenart J, Salinska E. MicroRNA in brain pathology: neurodegeneration the other side of the brain cancer. Noncoding RNA. 2019;5:20.","journal-title":"Noncoding RNA"},{"key":"3242_CR49","doi-asserted-by":"publisher","first-page":"1159","DOI":"10.1016\/j.bbapap.2008.04.028","volume":"1784","author":"Q Zhang","year":"2008","unstructured":"Zhang Q, Wang Y. High mobility group proteins and their post-translational modifications. BBA Proteins Proteom. 2008;1784:1159\u201366.","journal-title":"BBA Proteins Proteom"},{"key":"3242_CR50","doi-asserted-by":"publisher","first-page":"2978","DOI":"10.1021\/pr900087r","volume":"8","author":"R Sgarra","year":"2009","unstructured":"Sgarra R, Maurizio E, Zammitti S, Lo Sardo A, Giancotti V, Manfioletti G. Macroscopic differences in HMGA oncoproteins post-translational modifications: C-terminal phosphorylation of HMGA2 affects its DNA binding properties. J Proteome Res. 2009;8:2978\u201389.","journal-title":"J Proteome Res"},{"key":"3242_CR51","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-017-04179-6","volume":"7","author":"YT Wang","year":"2017","unstructured":"Wang YT, Pan SH, Tsai CF, Kuo TC, Hsu YL, Yen HY, et al. Phosphoproteomics reveals HMGA1, a CK2 substrate, as a drug-resistant target in non-small cell lung cancer. Sci Rep. 2017;7:4021.","journal-title":"Sci Rep"},{"key":"3242_CR52","doi-asserted-by":"publisher","first-page":"4711","DOI":"10.1021\/pr700571d","volume":"6","author":"Q Zhang","year":"2007","unstructured":"Zhang Q, Wang Y. Homeodomain-interacting protein kinase-2 (HIPK2) phosphorylates HMGA1a at Ser-35, Thr-52, and Thr-77 and modulates its DNA binding affinity. J Proteome Res. 2007;6:4711\u20139.","journal-title":"J Proteome Res"},{"key":"3242_CR53","doi-asserted-by":"publisher","first-page":"4979","DOI":"10.1172\/JCI73730","volume":"123","author":"GM Pierantoni","year":"2013","unstructured":"Pierantoni GM, Rinaldo C, Mottolese M, Di Benedetto A, Esposito F, Soddu S, et al. High-mobility group A1 inhibits p53 by cytoplasmic relocalization of its proapoptotic activator HIPK2. J Clin Investig. 2013;123:4979.","journal-title":"J Clin Investig"},{"key":"3242_CR54","doi-asserted-by":"publisher","first-page":"8333","DOI":"10.1021\/bi000378+","volume":"39","author":"GC Banks","year":"2000","unstructured":"Banks GC, Li Y, Reeves R. Differential in vivo modifications of the HMGI (Y) nonhistone chromatin proteins modulate nucleosome and DNA interactions. Biochem. 2000;39:8333\u201346.","journal-title":"Biochem"},{"key":"3242_CR55","doi-asserted-by":"publisher","first-page":"3575","DOI":"10.1021\/bi027338l","volume":"42","author":"R Sgarra","year":"2003","unstructured":"Sgarra R, Diana F, Bellarosa C, Dekleva V, Rustighi A, Toller M, et al. During apoptosis of tumor cells HMGA1a protein undergoes methylation: identification of the modification site by mass spectrometry. Biochem. 2003;42:3575\u201385.","journal-title":"Biochem"},{"key":"3242_CR56","doi-asserted-by":"publisher","first-page":"11354","DOI":"10.1074\/jbc.M009521200","volume":"276","author":"F Diana","year":"2001","unstructured":"Diana F, Sgarra R, Manfioletti G, Rustighi A, Poletto D, Sciortino MT, et al. A link between apoptosis and degree of phosphorylation of high mobility group A1a protein in leukemic cells. J Biol Chem. 2001;276:11354\u201361.","journal-title":"J Biol Chem"},{"key":"3242_CR57","doi-asserted-by":"publisher","first-page":"923","DOI":"10.1158\/1535-7163.MCT-07-0540","volume":"7","author":"X Cao","year":"2008","unstructured":"Cao X, Clavijo C, Li X, Lin HH, Chen Y, Shih HM, et al. SUMOylation of HMGA2: selective destabilization of promyelocytic leukemia protein via proteasome. Mol Cancer Ther. 2008;7:923\u201334.","journal-title":"Mol Cancer Ther"},{"key":"3242_CR58","doi-asserted-by":"publisher","first-page":"436","DOI":"10.1158\/0008-5472.CAN-09-1212","volume":"70","author":"LM Resar","year":"2010","unstructured":"Resar LM. The high mobility group A1 gene: transforming inflammatory signals into cancer? Cancer Res. 2010;70:436\u20139.","journal-title":"Cancer Res"},{"key":"3242_CR59","first-page":"48","volume":"1799","author":"M Fedele","year":"2010","unstructured":"Fedele M, Fusco A. HMGA and cancer. BBA Gene Regul Mech. 2010;1799:48\u201354.","journal-title":"BBA Gene Regul Mech"},{"key":"3242_CR60","first-page":"2149","volume":"8","author":"J Wang","year":"2016","unstructured":"Wang J, Xu X, Mo S, Tian Y, Wu J, Zhang J, et al. Involvement of microRNA-1297, a new regulator of HMGA1, in the regulation of glioma cell growth in vivo and in vitro. Am J Transl Res. 2016;8:2149.","journal-title":"Am J Transl Res"},{"key":"3242_CR61","doi-asserted-by":"publisher","first-page":"3226","DOI":"10.1002\/cam4.1534","volume":"7","author":"S Zhang","year":"2018","unstructured":"Zhang S, Zhang H, Yu L. HMGA2 promotes glioma invasion and poor prognosis via a long-range chromatin interaction. Cancer Med. 2018;7:3226\u201339.","journal-title":"Cancer Med"},{"key":"3242_CR62","doi-asserted-by":"publisher","first-page":"1169","DOI":"10.1080\/14728222.2016.1220543","volume":"20","author":"M Colamaio","year":"2016","unstructured":"Colamaio M, Tosti N, Puca F, Mari A, Gattordo R, Kuzay Y, et al. HMGA1 silencing reduces stemness and temozolomide resistance in glioblastoma stem cells. Expert Opin Ther Targets. 2016;20:1169\u201379.","journal-title":"Expert Opin Ther Targets"},{"key":"3242_CR63","doi-asserted-by":"publisher","first-page":"1758","DOI":"10.3390\/biology14121758","volume":"14","author":"I Shahzadi","year":"2025","unstructured":"Shahzadi I, Ahsan T, Anwaar S, Zaman W, Xia H. Promoter hypomethylation unleashes HMGA1 to orchestrate immune evasion and therapy resistance across cancers. Biology. 2025;14:1758.","journal-title":"Biology"},{"key":"3242_CR64","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1016\/j.brainres.2011.01.105","volume":"1384","author":"H Fan","year":"2011","unstructured":"Fan H, Guo H, Zhang IY, Liu B, Luan L, Xu S, et al. The different HMGA1 expression of total population of glioblastoma cell line U251 and glioma stem cells isolated from U251. Brain Res. 2011;1384:9\u201314.","journal-title":"Brain Res"},{"key":"3242_CR65","doi-asserted-by":"publisher","first-page":"543","DOI":"10.1007\/s11060-011-0710-6","volume":"106","author":"B Pang","year":"2012","unstructured":"Pang B, Fan H, Zhang IY, Liu B, Feng B, Meng L, et al. HMGA1 expression in human gliomas and its correlation with tumor proliferation, invasion and angiogenesis. J Neurooncol. 2012;106:543\u20139.","journal-title":"J Neurooncol"},{"key":"3242_CR66","doi-asserted-by":"publisher","first-page":"769","DOI":"10.1016\/j.omtn.2020.12.029","volume":"23","author":"Y Zeng","year":"2021","unstructured":"Zeng Y, Que T, Lin J, Zhan Z, Xu A, Wu Z, et al. Oncogenic ZEB2\/miR-637\/HMGA1 signaling axis targeting vimentin promotes the malignant phenotype of glioma. Mol Ther Nucleic Acids. 2021;23:769\u201382.","journal-title":"Mol Ther Nucleic Acids"},{"key":"3242_CR67","doi-asserted-by":"publisher","first-page":"4903","DOI":"10.1038\/onc.2016.22","volume":"35","author":"H Lopez-Bertoni","year":"2016","unstructured":"Lopez-Bertoni H, Lal B, Michelson N, Guerrero-Cazares H, Quinones-Hinojosa A, Li Y, et al. Epigenetic modulation of a miR-296-5p: HMGA1 axis regulates Sox2 expression and glioblastoma stem cells. Oncogene. 2016;35:4903\u201313.","journal-title":"Oncogene"},{"key":"3242_CR68","doi-asserted-by":"publisher","first-page":"55","DOI":"10.1016\/j.canlet.2016.04.020","volume":"377","author":"H Kaur","year":"2016","unstructured":"Kaur H, Ali SZ, Huey L, H\u00fctt-Cabezas M, Taylor I, Mao XG, et al. The transcriptional modulator HMGA2 promotes stemness and tumorigenicity in glioblastoma. Cancer Lett. 2016;377:55\u201364.","journal-title":"Cancer Lett"},{"key":"3242_CR69","doi-asserted-by":"crossref","unstructured":"Zhou J, Wang P, Zhang R, Huang X, Dai H, Yuan L, et al. Association of HMGA2 polymorphisms with Glioma susceptibility in Chinese children. Pharmacogenomics Pers Med. 2021;601\u20137.","DOI":"10.2147\/PGPM.S310780"},{"key":"3242_CR70","doi-asserted-by":"publisher","first-page":"44365","DOI":"10.18632\/oncotarget.9744","volume":"7","author":"X Zhong","year":"2016","unstructured":"Zhong X, Liu X, Li Y, Cheng M, Wang W, Tian K, et al. HMGA2 sustains self-renewal and invasiveness of glioma-initiating cells. Oncotarget. 2016;7:44365.","journal-title":"Oncotarget"},{"key":"3242_CR71","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1038\/s41572-019-0063-6","volume":"5","author":"PA Northcott","year":"2019","unstructured":"Northcott PA, Robinson GW, Kratz CP, Mabbott DJ, Pomeroy SL, Clifford SC, et al. Medulloblastoma. Nat Rev Dis Prim. 2019;5:11.","journal-title":"Nat Rev Dis Prim"},{"key":"3242_CR72","doi-asserted-by":"publisher","first-page":"553","DOI":"10.1007\/s00401-011-0934-8","volume":"123","author":"KM Lau","year":"2012","unstructured":"Lau KM, Chan QKY, Pang JC, Ma FMT, Li KK, Yeung WW, et al. Overexpression of HMGA1 deregulates tumor growth via cdc25A and alters migration\/invasion through a cdc25A-independent pathway in medulloblastoma. Acta Neuropathol. 2012;123:553\u201371.","journal-title":"Acta Neuropathol"},{"key":"3242_CR73","doi-asserted-by":"publisher","first-page":"32424","DOI":"10.1021\/acsomega.3c02043","volume":"8","author":"M Mori","year":"2023","unstructured":"Mori M, Ghirga F, Amato B, Secco L, Quaglio D, Romeo I, et al. Selection of natural compounds with HMGA-interfering activities and cancer cell cytotoxicity. ACS Omega. 2023;8:32424\u201331.","journal-title":"ACS Omega"},{"key":"3242_CR74","doi-asserted-by":"crossref","unstructured":"Li KK, Qi Y, Xia T, Yao Y, Zhou L, Lau KM, Ng HK, et al. CRMP1 inhibits proliferation of medulloblastoma and is regulated by HMGA1. PLoS ONE. 2015;10:e0127910.","DOI":"10.1371\/journal.pone.0127910"},{"key":"3242_CR75","doi-asserted-by":"publisher","first-page":"48","DOI":"10.1186\/s40478-018-0548-7","volume":"6","author":"S Rivero-Hinojosa","year":"2018","unstructured":"Rivero-Hinojosa S, Lau LS, Stampar M, Staal J, Zhang H, Gordish-Dressman H, et al. Proteomic analysis of Medulloblastoma reveals functional biology with translational potential. Acta Neuropathol Commun. 2018;6:48.","journal-title":"Acta Neuropathol Commun"},{"key":"3242_CR76","doi-asserted-by":"publisher","first-page":"1967","DOI":"10.1158\/0008-5472.CAN-18-1787","volume":"79","author":"R Tao","year":"2019","unstructured":"Tao R, Murad N, Xu Z, Zhang P, Okonechnikov K, Kool M, et al. MYC drives group 3 medulloblastoma through transformation of Sox2+ astrocyte progenitor cells. Cancer Res. 2019;79:1967\u201380.","journal-title":"Cancer Res"},{"key":"3242_CR77","doi-asserted-by":"publisher","first-page":"i137","DOI":"10.1093\/neuonc\/noy059.485","volume":"20","author":"Y Arakawa","year":"2018","unstructured":"Arakawa Y, Liu B, Terada Y, Matsui Y, Hattori E, Sumiyoshi S, et al. MBRS-40. HMGA2 is a prognostic factor to induce malignant phenotype in medulloblastoma. Neuro Oncol. 2018;20:i137.","journal-title":"Neuro Oncol"},{"key":"3242_CR78","doi-asserted-by":"publisher","first-page":"379","DOI":"10.1016\/j.ccell.2016.02.001","volume":"29","author":"PD Johann","year":"2016","unstructured":"Johann PD, Erkek S, Zapatka M, Kerl K, Buchhalter I, Hovestadt V, et al. Atypical teratoid\/rhabdoid tumors are comprised of three epigenetic subgroups with distinct enhancer landscapes. Cancer Cell. 2016;29:379\u201393.","journal-title":"Cancer Cell"},{"key":"3242_CR79","doi-asserted-by":"publisher","first-page":"1179","DOI":"10.1158\/1078-0432.CCR-13-1452","volume":"20","author":"K Zhang","year":"2014","unstructured":"Zhang K, Gao H, Wu X, Wang J, Zhou W, Sun G, et al. Frequent overexpression of HMGA2 in human atypical teratoid\/rhabdoid tumor and its correlation with let-7a3\/let-7b miRNA. Clin Cancer Res. 2014;20:1179\u201389.","journal-title":"Clin Cancer Res"},{"key":"3242_CR80","doi-asserted-by":"publisher","first-page":"177","DOI":"10.1097\/NEN.0000000000000161","volume":"74","author":"H Kaur","year":"2015","unstructured":"Kaur H, H\u00fctt-Cabezas M, Weingart MF, Xu J, Kuwahara Y, Erdreich-Epstein A, et al. The chromatin-modifying protein HMGA2 promotes atypical teratoid\/rhabdoid cell tumorigenicity. J Neuropathol Exp Neurol. 2015;74:177\u201385.","journal-title":"J Neuropathol Exp Neurol"},{"key":"3242_CR81","doi-asserted-by":"publisher","first-page":"613","DOI":"10.1093\/neuonc\/noz235","volume":"22","author":"B Ho","year":"2020","unstructured":"Ho B, Johann PD, Grabovska Y, De Dieu Andrianteranagna MJ, Yao F, Fr\u00fchwald M, et al. Molecular subgrouping of atypical teratoid\/rhabdoid tumors a reinvestigation and current consensus. Neuro Oncol. 2020;22:613\u201324.","journal-title":"Neuro Oncol"},{"key":"3242_CR82","doi-asserted-by":"publisher","first-page":"1519","DOI":"10.1038\/modpathol.3800464","volume":"18","author":"P Hui","year":"2005","unstructured":"Hui P, Li N, Johnson C, De Wever I, Sciot R, Manfioletti G, et al. HMGA proteins in malignant peripheral nerve sheath tumor and synovial sarcoma: preferential expression of HMGA2 in malignant peripheral nerve sheath tumor. Mod Pathol. 2005;18:1519\u201326.","journal-title":"Mod Pathol"},{"key":"3242_CR83","doi-asserted-by":"publisher","first-page":"185","DOI":"10.1186\/s13046-019-1183-2","volume":"38","author":"K Yang","year":"2019","unstructured":"Yang K, Guo W, Ren T, Huang Y, Han Y, Zhang H, et al. Knockdown of HMGA2 regulates the level of autophagy via interactions between MSI2 and Beclin1 to inhibit NF1-associated malignant peripheral nerve sheath tumour growth. J Exp Clin Cancer Res. 2019;38:185.","journal-title":"J Exp Clin Cancer Res"},{"key":"3242_CR84","first-page":"2398","volume":"62","author":"P Finelli","year":"2002","unstructured":"Finelli P, Pierantoni GM, Giardino D, Losa M, Rodeschini O, Fedele M, et al. The High Mobility Group A2 gene is amplified and overexpressed in human prolactinomas. Cancer Res. 2002;62:2398\u2013405.","journal-title":"Cancer Res"},{"key":"3242_CR85","doi-asserted-by":"publisher","first-page":"257","DOI":"10.1038\/nrendo.2011.40","volume":"7","author":"S Melmed","year":"2011","unstructured":"Melmed S. Pathogenesis of pituitary tumors. Nat Rev Endocrinol. 2011;7:257\u201366.","journal-title":"Nat Rev Endocrinol"},{"key":"3242_CR86","doi-asserted-by":"publisher","first-page":"255","DOI":"10.1007\/s00701-006-1108-7","volume":"149","author":"ZI Carrim","year":"2007","unstructured":"Carrim ZI, Reeks GA, Chohan AW, Dunn LT, Hadley DM. Predicting impairment of central vision from dimensions of the optic chiasm in patients with pituitary adenoma. Acta Neurochir. 2007;149:255\u201360.","journal-title":"Acta Neurochir"},{"key":"3242_CR87","doi-asserted-by":"publisher","first-page":"722","DOI":"10.1038\/s41574-023-00886-5","volume":"19","author":"S Petersenn","year":"2023","unstructured":"Petersenn S, Fleseriu M, Casanueva FF, Giustina A, Biermasz N, Biller BM, et al. Diagnosis and management of prolactin-secreting pituitary adenomas: a Pituitary Society International Consensus Statement. Nat Rev Endocrinol. 2023;19:722\u201340.","journal-title":"Nat Rev Endocrinol"},{"key":"3242_CR88","doi-asserted-by":"publisher","first-page":"525","DOI":"10.1016\/j.beem.2009.05.004","volume":"23","author":"D Dworakowska","year":"2009","unstructured":"Dworakowska D, Grossman AB. The pathophysiology of pituitary adenomas. Best Pract Res Clin Endocrinol Metab. 2009;23:525\u201341.","journal-title":"Best Pract Res Clin Endocrinol Metab"},{"key":"3242_CR89","doi-asserted-by":"publisher","first-page":"63","DOI":"10.1159\/000079038","volume":"32","author":"M Korbonits","year":"2004","unstructured":"Korbonits M, Morris DG, Nanzer A, Kola B, Grossman AB. Role of regulatory factors in pituitary tumour formation. Front Horm Res. 2004;32:63\u201395.","journal-title":"Front Horm Res"},{"key":"3242_CR90","first-page":"39","volume":"2","author":"D D\u2019Angelo","year":"2015","unstructured":"D\u2019Angelo D, Esposito F, Fusco A. Epigenetic mechanisms leading to overexpression of HMGA proteins in human pituitary adenomas. Front Med. 2015;2:39.","journal-title":"Front Med"},{"key":"3242_CR91","doi-asserted-by":"publisher","first-page":"1302","DOI":"10.3390\/cancers11091302","volume":"11","author":"D D\u2019Angelo","year":"2019","unstructured":"D\u2019Angelo D, De Martino M, Arra C, Fusco A. Emerging role of USP8, HMGA, and non-coding RNAs in pituitary tumorigenesis. Cancers. 2019;11:1302.","journal-title":"Cancers"},{"key":"3242_CR92","doi-asserted-by":"crossref","unstructured":"Fedele M, Battista S, Kenyon L, Baldassarre G, Fidanza V, Klein-Szanto AJ, et al. Correction to: Overexpression of the HMGA2 gene in transgenic mice leads to the onset of pituitary adenomas. Oncogene. 2023;42:406.","DOI":"10.1038\/s41388-022-02535-z"},{"key":"3242_CR93","doi-asserted-by":"publisher","first-page":"867","DOI":"10.1677\/erc.1.01049","volume":"12","author":"GM Pierantoni","year":"2005","unstructured":"Pierantoni GM, Finelli P, Valtorta E, Giardino D, Rodeschini O, Esposito F, et al. High-mobility group A2 gene expression is frequently induced in non-functioning pituitary adenomas (NFPAs), even in the absence of chromosome 12 polysomy. Endocr Relat Cancer. 2005;12:867\u201374.","journal-title":"Endocr Relat Cancer"},{"key":"3242_CR94","doi-asserted-by":"publisher","first-page":"2045","DOI":"10.4161\/cc.5.18.3211","volume":"5","author":"M Fedele","year":"2006","unstructured":"Fedele M, Pierantoni GM, Visone R, Fusco A. Critical role of the HMGA2 gene in pituitary adenomas. Cell cycle. 2006;5:2045\u20138.","journal-title":"Cell cycle"},{"key":"3242_CR95","doi-asserted-by":"publisher","first-page":"1844","DOI":"10.1158\/0008-5472.CAN-08-4133","volume":"69","author":"I De Martino","year":"2009","unstructured":"De Martino I, Visone R, Wierinckx A, Palmieri D, Ferraro A, Cappabianca P, et al. HMGA proteins up-regulate CCNB2 gene in mouse and human pituitary adenomas. Cancer Res. 2009;69:1844\u201350.","journal-title":"Cancer Res"},{"key":"3242_CR96","doi-asserted-by":"publisher","first-page":"123","DOI":"10.1530\/ERC-11-0135","volume":"19","author":"D Palmieri","year":"2012","unstructured":"Palmieri D, Valentino T, De Martino I, Esposito F, Cappabianca P, Wierinckx A, et al. PIT1 upregulation by HMGA proteins has a role in pituitary tumorigenesis. Endocr Relat Cancer. 2012;19:123\u201335.","journal-title":"Endocr Relat Cancer"},{"key":"3242_CR97","doi-asserted-by":"publisher","first-page":"431","DOI":"10.1038\/modpathol.2008.202","volume":"22","author":"ZR Qian","year":"2009","unstructured":"Qian ZR, Asa SL, Siomi H, Siomi MC, Yoshimoto K, Yamada S, et al. Overexpression of HMGA2 relates to reduction of the let-7 and its relationship to clinicopathological features in pituitary adenomas. Mod Pathol. 2009;22:431\u201341.","journal-title":"Mod Pathol"},{"key":"3242_CR98","doi-asserted-by":"publisher","first-page":"3857","DOI":"10.1038\/onc.2011.557","volume":"31","author":"D Palmieri","year":"2012","unstructured":"Palmieri D, D\u2019Angelo D, Valentino T, De Martino I, Ferraro A, Wierinckx A, et al. Downregulation of HMGA-targeting microRNAs has a critical role in human pituitary tumorigenesis. Oncogene. 2012;31:3857\u201365.","journal-title":"Oncogene"},{"key":"3242_CR99","doi-asserted-by":"publisher","first-page":"501","DOI":"10.1111\/j.1365-2559.2010.03495.x","volume":"56","author":"EL Wang","year":"2010","unstructured":"Wang EL, Qian ZR, Rahman MM, Yoshimoto K, Yamada S, Kudo E, et al. Increased expression of HMGA1 correlates with tumour invasiveness and proliferation in human pituitary adenomas. Histopathol. 2010;56:501\u20139.","journal-title":"Histopathol"},{"key":"3242_CR100","doi-asserted-by":"publisher","DOI":"10.3389\/fendo.2020.596554","volume":"11","author":"M Chang","year":"2021","unstructured":"Chang M, Yang C, Bao X, Wang R. Genetic and epigenetic causes of pituitary adenomas. Front Endocrinol. 2021;11:596554.","journal-title":"Front Endocrinol"},{"key":"3242_CR101","doi-asserted-by":"publisher","first-page":"507","DOI":"10.1016\/j.ijdevneu.2004.07.007","volume":"22","author":"T Arendt","year":"2004","unstructured":"Arendt T. Neurodegeneration and plasticity. Int J Dev Neurosci. 2004;22:507\u201314.","journal-title":"Int J Dev Neurosci"},{"key":"3242_CR102","doi-asserted-by":"publisher","first-page":"1523","DOI":"10.1038\/nn.3537","volume":"16","author":"PJ McKinnon","year":"2013","unstructured":"McKinnon PJ. Maintaining genome stability in the nervous system. Nat Neurosci. 2013;16:1523\u20139.","journal-title":"Nat Neurosci"},{"key":"3242_CR103","doi-asserted-by":"publisher","first-page":"2284","DOI":"10.1016\/S0140-6736(21)00218-X","volume":"397","author":"BR Bloem","year":"2021","unstructured":"Bloem BR, Okun MS, Klein C. Parkinson\u2019s disease. Lancet. 2021;397:2284\u2013303.","journal-title":"Lancet"},{"key":"3242_CR104","doi-asserted-by":"publisher","first-page":"1951","DOI":"10.1159\/000491465","volume":"47","author":"S Paladino","year":"2018","unstructured":"Paladino S, Conte A, Caggiano R, Pierantoni GM, Faraonio R. Nrf2 pathway in age-related neurological disorders: insights into MicroRNAs. Cell Physiol Biochem. 2018;47:1951\u201376.","journal-title":"Cell Physiol Biochem"},{"key":"3242_CR105","first-page":"1817","volume":"41","author":"JD Guo","year":"2018","unstructured":"Guo JD, Zhao X, Li Y, Li GR, Liu XL. Damage to dopaminergic neurons by oxidative stress in Parkinson\u2019s disease. Int J Mol Med. 2018;41:1817\u201325.","journal-title":"Int J Mol Med"},{"key":"3242_CR106","doi-asserted-by":"publisher","first-page":"1383","DOI":"10.4103\/1673-5374.300980","volume":"16","author":"J Dorszewska","year":"2021","unstructured":"Dorszewska J, Kowalska M, Prendecki M, Piekut T, Koz\u0142owska J, Kozubski W. Oxidative stress factors in Parkinson\u2019s disease. Neural Regen Res. 2021;16:1383\u201391.","journal-title":"Neural Regen Res"},{"key":"3242_CR107","doi-asserted-by":"publisher","DOI":"10.3389\/fncel.2020.620020","volume":"14","author":"G Li","year":"2021","unstructured":"Li G, Luo W, Wang B, Qian C, Ye Y, Li Y, et al. HMGA1 induction of miR-103\/107 forms a negative feedback loop to regulate autophagy in MPTP model of Parkinson\u2019s disease. Front Cell Neurosci. 2021;14:620020.","journal-title":"Front Cell Neurosci"},{"key":"3242_CR108","doi-asserted-by":"publisher","first-page":"1948","DOI":"10.1038\/cdd.2017.117","volume":"24","author":"A Conte","year":"2017","unstructured":"Conte A, Paladino S, Bianco G, Fasano D, Gerlini R, Tornincasa M, et al. High mobility group A1 protein modulates autophagy in cancer cells. Cell Death Differ. 2017;24:1948\u201362.","journal-title":"Cell Death Differ"},{"key":"3242_CR109","doi-asserted-by":"publisher","first-page":"4008","DOI":"10.1007\/s12010-023-04740-2","volume":"196","author":"C Zhong","year":"2024","unstructured":"Zhong C, Zhang Q, Bao H, Li Y, Nie C. Hsa_circ_0054220 upregulates HMGA1 by the competitive RNA pattern to promote neural impairment in MPTP model of Parkinson\u2019s disease. Appl Biochem Biotechnol. 2024;196:4008\u201323.","journal-title":"Appl Biochem Biotechnol"},{"key":"3242_CR110","doi-asserted-by":"publisher","first-page":"783","DOI":"10.1007\/s12013-024-01510-7","volume":"83","author":"D Xu","year":"2025","unstructured":"Xu D, Fan W, Fu B, Nie H. HMGA1 regulates IRS2 to promote inflammatory responses and oxidative stress injury in MPP+-induced cells. Cell Biochem Biophys. 2025;83:783\u201392.","journal-title":"Cell Biochem Biophys"},{"key":"3242_CR111","doi-asserted-by":"publisher","first-page":"820","DOI":"10.3892\/mmr.2021.12461","volume":"24","author":"Y Huang","year":"2021","unstructured":"Huang Y, Liu Y, Huang J, Gao L, Wu Z, Wang L, et al. Let-7b-5p promotes cell apoptosis in Parkinson\u2019s disease by targeting HMGA2. Mol Med Rep. 2021;24:820.","journal-title":"Mol Med Rep"},{"key":"3242_CR112","doi-asserted-by":"publisher","DOI":"10.1002\/jbt.23530","volume":"38","author":"H Bao","year":"2024","unstructured":"Bao H, Zhang Q, Li Y, Nie C. CircDLGAP4 overexpression ameliorates neuronal injury in Parkinson\u2019s disease by binding to EIF4A3 and increasing HMGA2 expression. J Biochem Mol Toxicol. 2024;38:e23530.","journal-title":"J Biochem Mol Toxicol"},{"key":"3242_CR113","doi-asserted-by":"publisher","first-page":"173","DOI":"10.1007\/s13311-021-01146-y","volume":"19","author":"JA Trejo-Lopez","year":"2022","unstructured":"Trejo-Lopez JA, Yachnis AT, Prokop S. Neuropathology of Alzheimer\u2019s disease. Neurotherapeutics. 2022;19:173\u201385.","journal-title":"Neurotherapeutics"},{"key":"3242_CR114","doi-asserted-by":"publisher","first-page":"698","DOI":"10.1038\/sj.cdd.4401221","volume":"10","author":"T Manabe","year":"2003","unstructured":"Manabe T, Katayama T, Sato N, Gomi F, Hitomi J, Yanagita T, et al. Induced HMGA1a expression causes aberrant splicing of presenilin-2 pre-mRNA in sporadic Alzheimer\u2019s disease. Cell Death Differ. 2003;10:698\u2013708.","journal-title":"Cell Death Differ"},{"key":"3242_CR115","doi-asserted-by":"publisher","first-page":"2220","DOI":"10.1128\/MCB.00114-10","volume":"30","author":"K Ohe","year":"2010","unstructured":"Ohe K, Mayeda A. HMGA1a trapping of U1 snRNP at an authentic 5\u2032 splice site induces aberrant exon skipping in sporadic Alzheimer\u2019s disease. Mol Cell Biol. 2010;30:2220\u20138.","journal-title":"Mol Cell Biol"},{"key":"3242_CR116","doi-asserted-by":"publisher","first-page":"67","DOI":"10.1016\/j.jchemneu.2003.12.004","volume":"28","author":"T Katayama","year":"2004","unstructured":"Katayama T, Imaizumi K, Manabe T, Hitomi J, Kudo T, Tohyama M. Induction of neuronal death by ER stress in Alzheimer\u2019s disease. J Chem Neuroanat. 2004;28:67\u201378.","journal-title":"J Chem Neuroanat"},{"key":"3242_CR117","doi-asserted-by":"publisher","first-page":"1179","DOI":"10.1111\/j.1365-2443.2007.01123.x","volume":"12","author":"T Manabe","year":"2007","unstructured":"Manabe T, Ohe K, Katayama T, Matsuzaki S, Yanagita T, Okuda H, et al. HMGA1a: sequence-specific RNA-binding factor causing sporadic Alzheimer\u2019s disease-linked exon skipping of presenilin-2 pre-mRNA. Genes Cells. 2007;12:1179\u201391.","journal-title":"Genes Cells"},{"key":"3242_CR118","doi-asserted-by":"publisher","first-page":"28","DOI":"10.1186\/s13024-022-00533-z","volume":"17","author":"Y Zhang","year":"2022","unstructured":"Zhang Y, Wu KM, Yang L, Dong Q, Yu JT. Tauopathies: new perspectives and challenges. Mol Neurodegener. 2022;17:28.","journal-title":"Mol Neurodegener"},{"key":"3242_CR119","doi-asserted-by":"crossref","unstructured":"Mirabelli M, Chiefari E, Arcidiacono B, Salatino A, Pascarella A, Morelli M, et al. HMGA1 deficiency: a pathogenic link between tau pathology and insulin resistance. EBioMedicine. 2025;115.","DOI":"10.1016\/j.ebiom.2025.105700"},{"key":"3242_CR120","first-page":"4632","volume":"13","author":"X Liu","year":"2021","unstructured":"Liu X, Wang H, Bei J, Zhao J, Jiang G, Liu X. The protective role of miR-132 targeting HMGA2 through the PI3K\/AKT pathway in mice with Alzheimer\u2019s disease. Am J Trans Res. 2021;13:4632.","journal-title":"Am J Trans Res"},{"key":"3242_CR121","doi-asserted-by":"publisher","first-page":"24","DOI":"10.1038\/s41572-019-0074-3","volume":"5","author":"T Klockgether","year":"2019","unstructured":"Klockgether T, Mariotti C, Paulson HL. Spinocerebellar ataxia. Nat Rev Dis Prim. 2019;5:24.","journal-title":"Nat Rev Dis Prim"},{"key":"3242_CR122","doi-asserted-by":"publisher","first-page":"1432","DOI":"10.1038\/onc.2008.495","volume":"28","author":"I De Martino","year":"2009","unstructured":"De Martino I, Visone R, Fedele M, Petrocca F, Palmieri D, Hoyos JM, et al. Regulation of microRNA expression by HMGA1 proteins. Oncogene. 2009;28:1432\u201342.","journal-title":"Oncogene"},{"key":"3242_CR123","doi-asserted-by":"publisher","first-page":"2668","DOI":"10.1016\/j.ejca.2008.07.033","volume":"44","author":"F Pentimalli","year":"2008","unstructured":"Pentimalli F, Palmieri D, Pacelli R, Garbi C, Cesari R, Martin E, et al. HMGA1 protein is a novel target of the ATM kinase. Eur J Cancer. 2008;44:2668\u201379.","journal-title":"Eur J Cancer"},{"key":"3242_CR124","doi-asserted-by":"publisher","first-page":"523","DOI":"10.3390\/ijms23010523","volume":"23","author":"S Ueno","year":"2022","unstructured":"Ueno S, Sudo T, Hirasawa A. ATM: functions of ATM kinase and its relevance to hereditary tumors. Int J Mol Sci. 2022;23:523.","journal-title":"Int J Mol Sci"},{"key":"3242_CR125","doi-asserted-by":"publisher","first-page":"3024","DOI":"10.1038\/onc.2011.21","volume":"30","author":"D Palmieri","year":"2011","unstructured":"Palmieri D, Valentino T, D\u2019Angelo D, De Martino I, Postiglione I, Pacelli R, et al. HMGA proteins promote ATM expression and enhance cancer cell resistance to genotoxic agents. Oncogene. 2011;30:3024\u201335.","journal-title":"Oncogene"},{"key":"3242_CR126","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1080\/10717544.2022.2154409","volume":"30","author":"Y Zhao","year":"2023","unstructured":"Zhao Y, Yue P, Peng Y, Sun Y, Chen X, Zhao Z, et al. Recent advances in drug delivery systems for targeting brain tumors. Drug Deliv. 2023;30:1\u201318.","journal-title":"Drug Deliv"},{"key":"3242_CR127","doi-asserted-by":"publisher","first-page":"2007","DOI":"10.1039\/D3BM02003G","volume":"12","author":"MJB Boyetey","year":"2024","unstructured":"Boyetey MJB, Choi Y, Lee HY, Choi J. Nanotechnology-based delivery of therapeutics through the intranasal pathway and the blood\u2013brain barrier for Alzheimer\u2019s disease treatment. Biomater Sci. 2024;12:2007\u201318.","journal-title":"Biomater Sci"}],"container-title":["Cell Death Discovery"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41420-026-03242-4","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41420-026-03242-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41420-026-03242-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,10,6]],"date-time":"2026-10-06T01:05:09Z","timestamp":1791248709000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41420-026-03242-4"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,7,11]]},"references-count":127,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["3242"],"URL":"https:\/\/doi.org\/10.1038\/s41420-026-03242-4","relation":{},"ISSN":["2058-7716"],"issn-type":[{"value":"2058-7716","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,7,11]]},"assertion":[{"value":"24 March 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"3 June 2026","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"29 June 2026","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"11 July 2026","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","label":"Competing interests","group":{"name":"EthicsHeading","label":"Ethics"}}],"article-number":"400"}}